Promis Neurosciences Stock Probability of Future Stock Price Finishing Over 15.33
| PMN Stock | USD 0.92 0.11 10.68% |
ProMIS |
ProMIS Neurosciences Target Price Odds to finish over 15.33
The tendency of ProMIS Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 15.33 or more in 90 days |
| 0.92 | 90 days | 15.33 | close to zero percent |
Based on a normal probability distribution, the odds of ProMIS Neurosciences to move over $ 15.33 or more in 90 days from now is close to zero percent (This ProMIS Neurosciences probability density function shows the probability of ProMIS Stock to fall within a particular range of prices over 90 days) . Probability of ProMIS Neurosciences price to stay between its current price of $ 0.92 and $ 15.33 at the end of the 90-day period is more than 93.0 .
Considering the 90-day investment horizon ProMIS Neurosciences has a beta of -0.9 indicating Additionally ProMIS Neurosciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. ProMIS Neurosciences Price Density |
| Price |
Predictive Modules for ProMIS Neurosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ProMIS Neurosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.ProMIS Neurosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. ProMIS Neurosciences is not an exception. The market had few large corrections towards the ProMIS Neurosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ProMIS Neurosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ProMIS Neurosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.32 | |
β | Beta against Dow Jones | -0.9 | |
σ | Overall volatility | 0.14 | |
Ir | Information ratio | -0.12 |
ProMIS Neurosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ProMIS Neurosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ProMIS Neurosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| ProMIS Neurosciences generated a negative expected return over the last 90 days | |
| ProMIS Neurosciences has some characteristics of a very speculative penny stock | |
| ProMIS Neurosciences has high historical volatility and very poor performance | |
| ProMIS Neurosciences has a very high chance of going through financial distress in the upcoming years | |
| Reported Net Loss for the year was (17.51 M) with loss before taxes, overhead, and interest of (16.09 M). | |
| ProMIS Neurosciences has about 8.95 M in cash with (14.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.24, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| ProMIS Neurosciences has a frail financial position based on the latest SEC disclosures | |
| Roughly 45.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: Disposition of 4817 shares by Johanne Kaplan of ProMIS Neurosciences at 28.8 subject to Rule 16b-3 |
ProMIS Neurosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ProMIS Stock often depends not only on the future outlook of the current and potential ProMIS Neurosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ProMIS Neurosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 12.3 M | |
| Cash And Short Term Investments | 16.8 M | |
| Shares Float | 9.2 M |
ProMIS Neurosciences Technical Analysis
ProMIS Neurosciences' future price can be derived by breaking down and analyzing its technical indicators over time. ProMIS Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of ProMIS Neurosciences. In general, you should focus on analyzing ProMIS Stock price patterns and their correlations with different microeconomic environments and drivers.
ProMIS Neurosciences Predictive Forecast Models
ProMIS Neurosciences' time-series forecasting models is one of many ProMIS Neurosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary ProMIS Neurosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about ProMIS Neurosciences
Checking the ongoing alerts about ProMIS Neurosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for ProMIS Neurosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| ProMIS Neurosciences generated a negative expected return over the last 90 days | |
| ProMIS Neurosciences has some characteristics of a very speculative penny stock | |
| ProMIS Neurosciences has high historical volatility and very poor performance | |
| ProMIS Neurosciences has a very high chance of going through financial distress in the upcoming years | |
| Reported Net Loss for the year was (17.51 M) with loss before taxes, overhead, and interest of (16.09 M). | |
| ProMIS Neurosciences has about 8.95 M in cash with (14.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.24, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| ProMIS Neurosciences has a frail financial position based on the latest SEC disclosures | |
| Roughly 45.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: Disposition of 4817 shares by Johanne Kaplan of ProMIS Neurosciences at 28.8 subject to Rule 16b-3 |
Check out ProMIS Neurosciences Backtesting, ProMIS Neurosciences Valuation, ProMIS Neurosciences Correlation, ProMIS Neurosciences Hype Analysis, ProMIS Neurosciences Volatility, ProMIS Neurosciences History as well as ProMIS Neurosciences Performance. To learn how to invest in ProMIS Stock, please use our How to Invest in ProMIS Neurosciences guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProMIS Neurosciences. If investors know ProMIS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProMIS Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.04 | Revenue Per Share 0.001 | Return On Assets (4.81) | Return On Equity (10.99) |
The market value of ProMIS Neurosciences is measured differently than its book value, which is the value of ProMIS that is recorded on the company's balance sheet. Investors also form their own opinion of ProMIS Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is ProMIS Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProMIS Neurosciences' market value can be influenced by many factors that don't directly affect ProMIS Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProMIS Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProMIS Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProMIS Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.